Skip to main content

Table 2 Clinical and demographic characteristics of recurrent TB cases treated for drug susceptible TB in Zambia, southern province

From: Urban-rural disparities in treatment outcomes among recurrent TB cases in Southern Province, Zambia

Characteristic

Level

Total

Urban areas

Rural areas

  

n (percent)

n (percent)

n (percent)

Sex

Female

1482 (41.7)

1045 (40.7)

437 (44.1)

male

2019 (56.9)

1473 (57.4)

546 (55.2)

Missing

54 (1.52)

47 (1.8)

7 (0.7)

Age groupa

10 & below

128 (3.6)

93 (3.6)

35 (3.5)

11–18

140 (3.9)

103 (4.0)

37 (3.7)

19–55

2185 (79.2)

2064 (80.5)

751 (75.9)

56 & older

403 (11.3)

259 (10.1)

144 (14.6)

Missing

69 (1.9)

46 (1.8)

23 (2.3)

Microbiological confirmation

clinical

2519 (70.9)

1874 (73.1)

639 (64.6)

confirmed

1036 (29.1)

689 (26.9)

347 (35.1)

Reason for retreatment

Relapse patients

2745 (77.2)

2126 (82.9)

619 (62.5)

Other

644 (18.1)

330 (12.9)

314 (31.7)

Treatment after LTFU patients

31 (0.8)

28 (1.1)

3 (0.3)

Treatment after failure patients

29 (0.82)

15 (0.6)

14 (1.4)

Missing

106 (3.0)

66 (2.6)

40 (4.0)

Site of disease

Pulmonary

2937 (82.6)

2086 (81.3)

851 (86.0)

Extra-pulmonary

537 (15.1)

418 (16.3)

119 (12.0)

Missing

81 (2.3)

61 (2.4)

20 (2.0)

Treatment Delay

14 days & less

3135 (88.2)

2286 (89.1)

849 (85.8)

15 days and more

420 (11.8)

279 (10.9)

141 (14.2)

Calendar year

< 2010

1884 (53)

1336 (52.1)

548 (55.4)

2010 & after

1671 (47)

1229 (47.9)

442 (44.7)

Facility type

Hospital

1353 (38.1)

926 (36.1)

427 (43.1)

Health Center or clinic

2202 (61.9)

1639 (63.9)

563 (56.9)

HIV status

Negative

1382 (38.9)

853 (61.7)

529 (38.3)

Positive

2173 (61.1)

1712 (78.8)

461 (21.2)

  1. aAge group (< 10, 11–18, 19–55 and > 55) classification was based a WHO pediatric treatment guidelines and other previous studies of TB treatment outcomes [13, 14].